SCHEMBL26324865

SCHEMBL26324865

CC(C)OC(=O)C(C(C)C)N(CC(F)(F)F)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
NR1I2 O75469 2/20 0.36
NR1H2 P55055 3/20 0.36
NR1H3 Q13133 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
MLYCD O95822 1/20 0.35
LMNA P02545 2/20 0.34
PDCD1 Q15116 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BTN3A1 O00481 1/20 0.34
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25440061 0.86 TSHR (0.40) TSHRNR1I2NR1H2NR1H3SMN1; SMN2
SCHEMBL26324864 0.82 KMT2A (0.34) TSHRBTN3A1MMP2MMP9MMP8
SCHEMBL26324941 0.81 TSHR (0.46) TSHRSMN1; SMN2CHRNB2CHRNB4CHRNA3
SCHEMBL26324890 0.78 ALDH1A1 (0.39) TSHRSMN1; SMN2GAALMNAMAPT
SCHEMBL26324920 0.78 TSHR (0.44) TSHRCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL11680056 0.77 KCNH2 (0.42) NR1I2NR1H2NR1H3SMN1; SMN2MLYCD
SCHEMBL26324800 0.76 TSHR (0.42) TSHRSMN1; SMN2GAACHRNB2CHRNB4
SCHEMBL26324873 0.75 TSHR (0.41) TSHRSMN1; SMN2GAACHRNB2CHRNB4
SCHEMBL26324862 0.74 BTN3A1 (0.39) TSHRSMN1; SMN2GAACHRNB2CHRNB4
SCHEMBL11679086 0.73 NR1I2 (0.44) NR1I2NR1H2NR1H3SMN1; SMN2MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TSHR 2716/4885NR1I2 3981/4885NR1H2 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.